BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38894148

about

Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.Marked for death: targeting epigenetic changes in cancer.Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.Up-regulation of RNF187 induces hepatocellular carcinoma cell epithelial to mesenchymal transitions.Targeting bromodomain and extraterminal proteins in breast cancer.

P2860

Q33761645-92669558-D016-4313-A5AB-6F4371A11FE7 Q37362732-A37C2D77-88FC-4D0A-97A7-3FB3E1312150 Q38734040-3DE9E29D-C4B3-495E-A5DF-456B272F7495 Q38747872-7EDB3490-6A35-432A-8DD1-40567626C327 Q38828743-B4AA2CB5-3A82-4F15-BDAB-F198C9FAEE98 Q38909048-6C9CDA27-5A6C-4796-81ED-2ABE885D8514 Q39236663-1E5F8CB7-02FA-4BC7-86DC-FCFEE4913AD0 Q39924163-67FFAA2A-91C0-4633-A5DC-0B634E808EA1 Q47101387-F0E0D220-F27A-4CB2-8A0C-119C6B761926 Q47385983-A8C5B8C2-B07D-4ECB-B006-EFBB3A2A83BE

P2860

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q38894148

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

BRD4 promotes tumor growth and ...... n in hepatocellular carcinoma.

@en

type

label

BRD4 promotes tumor growth and ...... n in hepatocellular carcinoma.

@en

prefLabel

BRD4 promotes tumor growth and ...... n in hepatocellular carcinoma.

@en

P1433

Q38894148-A8ABCA5C-C627-4BC7-8058-E554E8D43C2C

P1476

Q38894148-D6061F80-8D44-4319-9B15-6F1B99C8B9B8

P2093

Q38894148-1AD20E75-B0B5-46EF-A6B3-569A5E054B54

Q38894148-2EA4154C-EEDD-4471-9080-32E5DD3709D2

Q38894148-41C20811-E660-491F-8575-43E3293B1EFD

Q38894148-5BA1F757-5230-4379-8029-7F5355E5D58D

Q38894148-6856ED0F-C68C-496D-ACFD-7D2B137402F1

Q38894148-70C7B48A-E866-43E6-9BDB-D81F94B19D41

Q38894148-BC920042-0408-4243-97B7-ADED33BC98E6

Q38894148-C6C56009-061A-4482-9674-ED3F2AA702CD

Q38894148-D13861C7-5233-42EF-8870-CA9A781D1B85

P2860

Q38894148-10AF0DF8-F6B3-480A-B6CE-258AA304B853

Q38894148-14F4174E-9E87-4682-AAC3-524E5F65EE84

Q38894148-1807F3FC-AD09-46F7-A63D-3C0A8A6CE5E8

Q38894148-2956605F-69F4-4E0C-BE94-8173302D1240

Q38894148-29930FC3-3930-4653-A96D-ED2E183F1983

Q38894148-2DC82DFB-5674-4EB1-9569-CC072805DA52

Q38894148-2FBAEEB6-8DA3-4908-BEED-6DC6AD9CE863

Q38894148-32537074-26F3-41A1-9DB7-82BC23F9C74A

Q38894148-36E32402-05A9-4050-B7E3-6FF34933F9E8

Q38894148-40C31911-B963-4BEE-9537-B0302A2B9954

P304

Q38894148-786E4B8F-A4F3-4976-8F45-CCAAB52463BA

P31

Q38894148-E69F4596-F2C6-4C43-8981-53143322C7E5

P356

Q38894148-AC0E7E9B-0044-48C8-9C82-8296E02B87E0

P433

Q38894148-D1FD8FD6-F246-46CF-9B8F-CC0A4F2295B3

P478

Q38894148-27E935C7-ACDD-4D42-830B-B4BED68C9BDA

P577

Q38894148-4D9F5F3E-6AEF-48AF-B678-1A0CC513C931

P698

Q38894148-D1021E4D-8320-4309-9B95-D4F7D953E950

P356

0394632015572070

P1433

International Journal of Immunopathology and Pharmacology

P1476

BRD4 promotes tumor growth and ...... n in hepatocellular carcinoma.

@en

P2093

Aiwu Ke

http://www.w3.org/2001/XMLSchema#string

Chi Zhang

http://www.w3.org/2001/XMLSchema#string

Dongmei Gao

http://www.w3.org/2001/XMLSchema#string

Guoming Shi

http://www.w3.org/2001/XMLSchema#string

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Jiabin Cai

http://www.w3.org/2001/XMLSchema#string

Pengfei Zhang

http://www.w3.org/2001/XMLSchema#string

Zaozhuo Shen

http://www.w3.org/2001/XMLSchema#string

Zhaoru Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA

Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression

The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription

Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition

Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.

Epithelial-mesenchymal transitions in development and disease

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

P304

36-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0394632015572070

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25816404

http://www.w3.org/2001/XMLSchema#string